NEPHURE
Live / Registered — Registered (as of 10 Nov 2020)
What this means for you
Registered since 10 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88361318
- Registration number
- 6192502
- Mark type
- Stylized text
- Filed
- 28 Mar 2019
- Published for opposition
- 31 Dec 2019
- Registered
- 10 Nov 2020
- Attorney of record
- Amber N. Davis
Goods and services
- Class 005 — Pharmaceuticals: Oxalate-reducing enzyme dietary supplements for consumer use
Owner
- OXIDIEN PHARMACEUTICALS, LLC, GAINESVILLE, FL, US
- OXIDIEN PHARMACEUTICALS, LLC, GAINESVILLE, FL, US
- Captozyme Inc., Gainesville, FL, US
- Captozyme Inc., Gainesville, FL, US
Prosecution history
- 10 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Jan 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 10 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 02 Oct 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 17 Aug 2020 — NOTICE OF ALLOWANCE CANCELLED
- 02 Oct 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Aug 2020 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 07 Aug 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Aug 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Aug 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Apr 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Feb 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2019 — PUBLISHED FOR OPPOSITION
- 11 Dec 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED